ストックスクリーナーアプリを入手
370.85
2.61%
9.5199
Amgen Inc (AMGN) 最新ニュース
Amgen Inc. $AMGN Stake Lessened by Fulton Bank N.A. - MarketBeat
Amgen Secures Court Halt to Colorado Board’s Price Cap on Enbrel - Bloomberg Law News
Amgen Wins Order Blocking Colorado's Enbrel Price Cap - Law360
Judge blocks Colorado’s first-of-its-kind price cap on Amgen’s Enbrel By Reuters - Investing.com
Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel - Reuters
Controversial drug at center of multibillion-dollar Amgen deal faces more questions after paper retracted - The Business Journals
AMGNAMGEN Inc Options - Finviz
Amgen Inc. highlights its biotech pipeline as investors track long-term growth prospects - AD HOC NEWS
BMO Capital maintains Amgen stock rating citing Tavneos concerns - Investing.com
BMO Capital maintains Amgen stock rating citing Tavneos concerns By Investing.com - Investing.com Canada
Amgen or Biogen: Which Biotech Stock Appears Better Poised? - TradingView
BMO Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $400 - Moomoo
USS Investment Management Ltd Acquires 3,681 Shares of Amgen Inc. $AMGN - MarketBeat
Mizuho Highlights Amgen (AMGN) Pipeline Potential With MariTide and Olpasiran - Yahoo Finance
IFM Investors Pty Ltd Increases Holdings in Amgen Inc. $AMGN - MarketBeat
InflaRx seeks to fill void left by Amgen’s Tavneos in Europe - European Biotechnology Magazine
Amgen (AMGN) Faces EU Push To Revoke Tavneos Approval - Yahoo Finance
Viridian may have edge over Amgen in eye drug showdown, analysts argue - BioPharma Dive
Amgen Faces Fresh Pressure After NEJM Retracts Trial Behind $459 Million Drug - GuruFocus
Medication used to treat heart failure recalled nationwide - The Hill
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance
Pathway Financial Advisers LLC Sells 5,382 Shares of Amgen Inc. $AMGN - MarketBeat
Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now. - The Motley Fool
Forum Financial Management LP Sells 2,792 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Stock Weighs Strong Run Against Mixed Valuation Signals - Yahoo Finance
Heart and Kidney Medications Recalled Nationwide—Over 900,000 Bottles Affected - EatingWell
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings - Reuters
Amgen (AMGN) Faces Setback as Clinical Trial Article Retracted - GuruFocus
Amgen Drug Tavneos’ Main Study Retracted by Medical Journal - Bloomberg.com
Recall alert: Nearly 1M bottles of kidney, heart medications recalled - Boston 25 News
Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease - Benzinga
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $427 - Moomoo
Amgen Bases as Healthcare Ramps for NASDAQ:AMGN by TradeStation - TradingView
Matrix Asset Advisors Inc. NY Sells 3,739 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen advances obesity pipeline focus, shares hold near recent highs - AD HOC NEWS
Amgen Inc. $AMGN Holdings Lifted by Fort Washington Investment Advisors Inc. OH - MarketBeat
Amgen sets late-stage obesity data milestone, shares on watch for Wegovy and Zepbound competition - AD HOC NEWS
BLINCYTO from Amgen Inc.immunotherapy that reshapes leukemia care - Ad-hoc-news.de
FDA Approves Viridian’s Thyroid Eye Disease Drug, Competitor to a Blockbuster Amgen Med - MedCity News
Amgen Recalls Corlanor and Sensipar Tablets Over Foreign Substance RiskNews and Statistics - IndexBox
Amgen Sunday strategy focus, stock and pipeline under long-term scrutiny - Ad-hoc-news.de
Janney Montgomery Scott LLC Decreases Stake in Amgen Inc. $AMGN - MarketBeat
Nicholas Wealth LLC. Takes $1.16 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Pictet Asset Management Holding SA - MarketBeat
Nearly 1 million bottles of heart and kidney medication recalled over foreign substance found on tablets - Fox Business
Price to book forward of Amgen Inc. – NASDAQ:AMGN - TradingView
The Evenity from Amgen Inc.osteoporosis therapy with a defined 12-month window - Ad-hoc-news.de
Amgen updates phase 2 obesity data, shares closely watched by health investors - Ad-hoc-news.de
Amgen (AMGN) Faces EU Withdrawal Risk for Tavneos Due to Data In - GuruFocus
900,000 Bottles of Heart and Kidney Medications Recalled For 'Unexpected Foreign Matter' in Bottles - People.com
Nearly 1 million bottles of medication used to treat heart failure recalled nationwide - PIX11
EMA: Amgen, Vifor Inflammatory Drug’s Benefits No Longer Outweigh Risks - MedCity News
What Does Rep. Salazar's Amgen Purchase Signify for Biotech Investors - Kavout | AI
Amgen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.03571 Sh - TradingView
Amgen Continues To Perform (NASDAQ:AMGN) - Seeking Alpha
Amgen Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Enterprise value to EBIT forward of Amgen Inc. – MUN:AMG - TradingView
Enterprise value to EBIT forward of Amgen Inc. – NASDAQ:AMGN - TradingView
Amgen consensus steady ahead of next earnings, shares tracked against big pharma peers - Ad-hoc-news.de
Enterprise value to EBIT forward of Amgen Inc. Shs Cert Deposito Arg Repr 0.033333 Shs – BCBA:AMGDB - TradingView
Amgen Inc. Actuals & Estimates (NASDAQ:AMGN) - TradingView
EU regulator backs revoking Amgen's right to sell rare-disease drug - Reuters
European Regulator Calls for Amgen’s Tavneos to Have Authorization Revoked - WSJ
2.68%
大文字化:
|
ボリューム (24 時間):